|
Streptococcus
pyogenes
(Group A β-hemolytic
Streptococcus)
Read the Chapter
Sliding Table of
Contents on the left of the screen
Tables and
Figures
Table 1: In Vitro Susceptibilities of Streptococcus
pyogenes to Common Antibiotics
Table 2:
Suggested
Antibiotics, Doses and Duration For Treatment of Streptococcus pyogenes
Infections
Vignettes
[Benedek TG.
The History of Bacteriologic Concepts of Rheumatic Fever
and Rheumatoid Arthritis. Semin
Arthritis Rheum 2006;36:109-123.]
Gould IM.
Alexander Gordon, puerperal sepsis, and modern
theories of infection control--Semmelweis in perspective.
Lancet Infect Dis. 2010 Apr;10:275-8.
Bliziotis IA, Ntziora F, et al.
Rifampin as adjuvant treatment of Gram-positive
bacterial infections: a systematic review of comparative clinical trials.
Eur J Clin Microbiol Infect Dis. 2007 Dec;26:849-56.
Shah S, et al.
Intravenous Immunoglobulin in Children with
Streptococcal Toxic Shock Syndrome. Clin Infect Dis
2009;49:1369-1376.
Authors
Judith Martin, M.D. and
Dennis L. Stevens, Ph.D., M.D.
First Edition (1998): Raymond D. Pitetti and Dennis P. Stevens
|
www.antimicrobe.org